Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC)

Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with increasing incidences worldwide. The overall 5-year survival rate remains low, underscoring the urgent need for effective therapies. Despite the promising efficacy of immunotherapy for various solid tumors, its benefits for pancreatic c...

Full description

Bibliographic Details
Published in:	Cancer Pathogenesis and Therapy
Main Authors:	Runjie Liu, Jianang Li, Liang Liu, Wenquan Wang, Jinbin Jia
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Subjects:	Pancreatic cancer Macrophages Tumor microenvironment Immunosuppression
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949713224000557

Similar Items

Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status
by: E.B. Faber, et al.
Published: (2024-06-01)

Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies
by: Songyu Guo, et al.
Published: (2024-03-01)

Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
by: Remya P. G. Ramesh, et al.
Published: (2025-03-01)

Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment
by: Etienne D. Foucher, et al.
Published: (2018-05-01)

Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
by: Jinlu Liu, et al.
Published: (2023-10-01)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
by: Ying Li, et al.
Published: (2023-03-01)

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
by: Jingchang Zhang, et al.
Published: (2022-07-01)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
by: Jannat Pervin, et al.
Published: (2023-10-01)

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
by: Ottavia De Simoni, et al.
Published: (2023-06-01)

Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma
by: Haizhen Luo, et al.
Published: (2024-09-01)

An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer
by: Jinglong Guo, et al.
Published: (2023-09-01)

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
by: Christian Prinz, et al.
Published: (2022-08-01)

Tumor microenvironment participates in metastasis of pancreatic cancer
by: Bo Ren, et al.
Published: (2018-07-01)

Immunosuppressive microenvironment in neuroblastoma
by: Vito ePistoia, et al.
Published: (2013-06-01)

Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
by: Hao Chen, et al.
Published: (2023-11-01)

PPY‐Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer
by: Mengdie Cao, et al.
Published: (2025-05-01)

Pancreatic Ductal Adenocarcinoma: The Characteristics of Contrast-Enhanced Ultrasound Are Correlated with the Hypoxic Microenvironment
by: Lan Wang, et al.
Published: (2023-10-01)

S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study
by: Weiwei Hao, et al.
Published: (2023-10-01)

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
by: Di Wang, et al.
Published: (2023-06-01)

Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment
by: Jingze Leng, et al.
Published: (2024-09-01)

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
by: Wenyu Luo, et al.
Published: (2024-01-01)

Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment
by: Yuxi Qiao, et al.
Published: (2025-08-01)

Physico-chemical characterization of the tumour microenvironment of pancreatic ductal adenocarcinoma
by: Elena García-Gareta, et al.
Published: (2024-06-01)

Adjustable extracellular matrix rigidity tumor model for studying stiffness dependent pancreatic ductal adenocarcinomas progression and tumor immunosuppression
by: Haoxiang Zhang, et al.
Published: (2023-05-01)

Research progress of the immunosuppressive tumor microenvironment in multiple myeloma
by: Yue WANG, et al.
Published: (2025-08-01)

CCN1 Enhances Tumor Immunosuppression through Collagen‐Mediated Chemokine Secretion in Pancreatic Cancer
by: Hongjie Fan, et al.
Published: (2025-06-01)

WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
by: Yin Wenke, et al.
Published: (2023-01-01)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
by: Wanxing Duan, et al.
Published: (2022-06-01)

In vivo visualization of immunosuppressive cells in the tumor microenvironment
by: Guangfa Bao, et al.
Published: (2023-09-01)

Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC
by: Liu X, et al.
Published: (2025-03-01)

Exosome-Mediated Immunosuppression in Tumor Microenvironments
by: Qi-Hui Xie, et al.
Published: (2022-06-01)

AXL: shapers of tumor progression and immunosuppressive microenvironments
by: Yihui Liu, et al.
Published: (2025-01-01)

Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma
by: Sarah Mansouri, et al.
Published: (2023-02-01)

Abnormalities in T cell subsets in the circulating immunity and tumor microenvironment in patients with pancreatic ductal adenocarcinoma
by: SU Bingwei, SHEN Baiyong
Published: (2025-03-01)

Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma
by: Mengwei Wu, et al.
Published: (2023-06-01)

Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
by: Yiliang Li, et al.
Published: (2018-07-01)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
by: Xuehua Zhang, et al.
Published: (2022-11-01)

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
by: Chin-King Looi, et al.
Published: (2019-04-01)

TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma
by: Shasha Li, et al.
Published: (2023-05-01)